Utah Governor and BioUtah Recognize Co-Diagnostics Following Saudi Arabia Joint Venture Announcement

Utah Governor Spencer Cox and BioUtah President and CEO Kelvyn Cullimore have formally recognized Co-Diagnostics, Inc. following the company's announcement of a new joint venture in the Kingdom of Saudi Arabia. The recognition highlights the Utah-based molecular diagnostics company's expanding international presence and its role in representing the state's life sciences industry on the global stage.

Governor Cox emphasized the significance of Co-Diagnostics' international expansion, stating that the company's growth across the Middle East and North Africa regions demonstrates the strength of Utah's life sciences sector and the determination of local entrepreneurs. The governor noted that Co-Diagnostics represents Utah's ability to compete internationally while developing tools that benefit patients worldwide through advanced diagnostic technologies.

Kelvyn Cullimore of BioUtah, the state's life sciences trade association, acknowledged Co-Diagnostics as an Elite member of the organization and highlighted how the company's joint venture agreement in Saudi Arabia confirms its expanding leadership position in the global diagnostics market. Cullimore expressed pride in how Co-Diagnostics represents Utah's life sciences community, which he described as one of the fastest-growing in the United States.

The joint venture, named CoMira Diagnostics, represents a strategic expansion for Co-Diagnostics into the Middle Eastern market. This move aligns with the company's focus on developing and manufacturing state-of-the-art molecular diagnostics technologies that detect and analyze nucleic acid molecules, including DNA and RNA. The company's proprietary technology platform also supports the development of tests for its Co-Dx PCR at-home and point-of-care platform, currently subject to regulatory review.

This international expansion has broader implications for Utah's economic development and the global diagnostics industry. The recognition from state leadership underscores how homegrown companies can achieve international success while bringing positive attention to their home state's business environment. For the diagnostics industry, Co-Diagnostics' expansion into Saudi Arabia represents continued globalization of advanced medical technologies and the growing importance of molecular diagnostics in healthcare systems worldwide.

The development also highlights the strategic importance of partnerships between public entities like the governor's office and industry organizations such as BioUtah in supporting local companies' global ambitions. As molecular diagnostics continue to play an increasingly critical role in global healthcare, Co-Diagnostics' expansion into new markets demonstrates how specialized technology companies can leverage their expertise to address international healthcare needs while driving economic growth in their home regions.